首页> 美国卫生研究院文献>ACS Omega >Facile Synthesis of Dabigatran Etexilate Mesylatean Anticoagulant Drug Using a Novel Synthon N-Hexyl-4-nitrophenylCarbonate
【2h】

Facile Synthesis of Dabigatran Etexilate Mesylatean Anticoagulant Drug Using a Novel Synthon N-Hexyl-4-nitrophenylCarbonate

机译:达比加群酯甲磺酸盐的简便合成一种抗凝血药使用新型Synthon N-己基-4-硝基苯基碳酸盐

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Facile synthesis for Dabigatran etexilate mesylate (>1), an anticoagulant drug, is reported using a novel synthon, n-hexyl-4-nitrophenyl carbonate (>32), which substantially eliminates the formation of potential impurities >20–>27, which were generated due to the use of n-hexyl chloroformate in previously reported methods. Pinner reaction to prepare a key and critical intermediate, amidine >8, was optimized using design of experiment software to establish critical process parameters to achieve >8 in 97% yield. Nucleophilic substitution of >8 with novel synthon n-hexyl-4-nitrophenyl carbonate (>32) furnished the dabigatran base >9, which was then converted to its mesylate salt using methane sulfonic acid to provide >1 with an overall yield of 66% over three steps.
机译:据报道,使用一种新型的合成子,正己基-4-硝基苯基碳酸酯(> 32 ),可以轻松合成抗凝药物达比加群酯甲磺酸盐(> 1 ),该合成剂可基本消除形成潜在的杂质> 20 – > 27 ,这些杂质是由于先前报道的方法中使用了氯甲酸正己酯而产生的。使用实验软件的设计优化了Pinner反应以制备关键和关键的中间体am > 8 ,以建立关键的工艺参数,从而以97%的收率实现> 8 。用新型合成子碳酸正己酯-4-硝基苯基碳酸酯(> 32 )对> 8 进行亲核取代,提供了达比加群碱> 9 ,然后将其转化为使用甲磺酸的甲磺酸盐提供> 1 ,分三步完成,总收率为66%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号